Top compounds associated with response to PRAMEF18


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.036 0.3
mRNA selumetinib:GDC-0941 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.037 0.3
mRNA bendamustine CTRPv2 pan-cancer AAC -0.039 0.3
mRNA CAY10594 CTRPv2 pan-cancer AAC -0.039 0.3
mRNA BRD-K84807411 CTRPv2 pan-cancer AAC -0.075 0.3
mRNA GW843682X CTRPv2 pan-cancer AAC -0.035 0.3
mRNA BRD-K78574327 CTRPv2 pan-cancer AAC -0.075 0.3
mRNA SKI-II CTRPv2 pan-cancer AAC -0.037 0.3
mRNA SR8278 CTRPv2 pan-cancer AAC 0.12 0.3
mRNA BRD9876 CTRPv2 pan-cancer AAC -0.038 0.3
Download CSV